InspireMD (NSPR.US) will release financial report before market open on November 12th.
$inspiremd (nspr.us)$ will release its financial report before the market opens on November 12th, investors are invited to pay attention. How was the previous performance? $inspiremd (nspr.us)$ had revenue of 1.739 million USD, net income of -7.909 million USD, and eps of -0.22 USD in 2024/Q2. In 2023/Q3, revenue was 1.556 million USD, net income was -5.178 million USD, and eps was -0.15 USD. The above data is based on the US_GAAP accounting standards. Futubull reminder: 1. Hong Kong and US-listed companies
Express News | InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12TH
One InspireMD Insider Raised Stake By 13% In Previous Year
InspireMD Expands With New Miami Headquarters
Express News | InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the Cguard Prime Carotid Stent System
InspireMD Inc (NSPR) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges